Taylor Wessing with finanzen.net founders on Inflexion sale

Inflexion, a European private equity firm, is buying Axel Springer’s shares in finanzen.net, Germany’s top financial portal. The deal also involves founders Jens Ohr, Peter Schille, and Dominik Nienhaus. They were advised by Taylor Wessing’s Marc-Oliver Kurth and Dr. Norman Röchert.

The agreement was signed on 14 November 2024. The transaction awaits merger and investment control approvals.

finanzen.net was founded in 2000. It became an independent company in 2010, with Axel Springer holding a majority stake.

Dr. Norman Röchert, LL.M., Partner (c) www.taylorwessing.com

The new management will merge three business units: Zero, Finanzen.net, and Traderfox. The goal is to expand savings and investment products, making finanzen.net a complete financial partner.

Jens Ohr and Peter Schille said, “Inflexion’s experience will accelerate growth. We thank Axel Springer for helping us transform finanzen.net. We look forward to growing with Inflexion.”

Marc-Oliver Kurth, LL.M. , Partner (c) www.taylorwessing.com

About finanzen.net
finanzen.net is Germany’s leading financial portal. It offers real-time market data, news, and tools for chart analysis and portfolio tracking. It has been part of Axel Springer SE since 2010.

About Inflexion
Inflexion is a top European private equity firm. It has offices in London, Manchester, Amsterdam, Stockholm, and Frankfurt. Inflexion manages £11bn in assets and helps companies grow.

Legal advisors

For detailed information, as well as the picture copyright, please see the law firm´s original article here: Taylor Wessing advises finanzen.net founding team

More news

Trending news

🔥 Is Chambers better than Legal 500? And if so, in which areas of law? And in which countries? And where
Silvia Romanelli joins FIVERS as Partner and Co-Managing Partner of the Rome office. She will work alongside Renato Giallombardo. She
Foglia & Partners has launched Interance. It is a joint venture with Aplos Consulting Srl. Aplos was founded by Silvia
Schalast advised Meliodays Medical GmbH on its pre-seed financing round. The round raised over €800,000. It was led by capacura